AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications validating its POSH (Pooled Optical Screening in Human cells) platform. The study ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Inside cells, DNA twists and coils itself into a variety of different secondary structures—including i-motifs (iMs) and ...

Using X-ray diffraction data, James Watson (1928-2025) made the seminal discovery of the double-helical structure of DNA ...

Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in ...

Watson Season 2 Episode 10 featured a worrying new story for Holmes on top of the most bizarre case yet. Our review!

The following players span a variety of industries, so if you pick up more than one, you may gain in diversification.

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...

Gene-edited goldenberries clear USDA review, moving closer to farms. Compact plants solve farming challenges for this ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...